Clinical Cancer Research Versailles No Abst Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwong, J.
Right arrow Articles by Huang, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwong, J.
Right arrow Articles by Huang, D. P.
Related Collections
Right arrowKey Article
Clinical Cancer Research Vol. 8, 131-137, January 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma1

Joseph Kwong2, Kwok-Wai Lo, Ka-Fai To, Peter M. L. Teo, Philip J. Johnson and Dolly Poon Huang

Departments of Anatomical and Cellular Pathology [J. K., K-W. L., K-F. T., D. P. H.] and Clinical Oncology [P. M. L. T., P. J. J.], Prince of Wales Hospital, and Institute of Molecular Oncology at the Sir Y. K. Pao Centre for Cancer [K-W. L., P. J. J., D. P. H.], The Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China

Purpose: The methylation profile of nasopharyngeal carcinoma (NPC) has been investigated by a candidate gene approach.

Experimental Design: Four NPC cell lines, 4 NPC xenografts, 33 NPC primary tumors, and 6 samples of normal nasopharyngeal epithelium were subjected to methylation-specific PCR for analysis of promoter methylation of eight cancer-related genes. These eight genes were RASSF1A, RARß2, DAP-kinase, p16, p15, p14, MGMT, and GSTP1. The correlation between methylation status of these genes and clinical features such as stage, local-regional recurrence, distant metastasis, and survival has been analyzed.

Results: The incidence of promoter methylation in NPC samples was 84% for RASSF1A, 80% for RARß2, 76% for DAP-kinase, 46% for p16, 17% for p15, 20% for p14, 20% for MGMT, and 3% for GSTP1. No methylation of these genes was detected in the six normal nasopharyngeal epithelium samples. All NPC tumor samples in this study displayed aberrant methylation in at least one of these eight genes. No significant correlation between methylation status of these genes and clinical parameters of the patients was found.

Conclusions: A high frequency of aberrant methylation of the 5' CpG island of the RASSF1A, RARß2, DAP-kinase, and p16 genes in the present study was noted. Our findings suggest that methylation of the genes in the critical pathways is common in NPC.


Key Article

The Potential Prognostic, Predictive, and Therapeutic Values of DNA Methylation in Cancer : Commentary re: J. Kwong et al., Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma. Clin. Cancer Res., 8: 131–137, 2002, and H-Z. Zou et al., Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients. Clin. Cancer Res., 8: 188–191, 2002.
Martin Widschwendter and Peter A. Jones
Clin. Cancer Res. 2002 8: 17-21. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
W. Zhou, X. Feng, H. Li, L. Wang, B. Zhu, W. Liu, M. Zhao, K. Yao, and C. Ren
Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma
Acta Biochim Biophys Sin, January 1, 2009; 41(1): 54 - 62.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al.
Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis
Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Zhang, Z. Li, Y. Cheng, F. Jia, R. Li, M. Wu, K. Li, and L. Wei
CpG Island Methylator Phenotype Association with Elevated Serum {alpha}-Fetoprotein Level in Hepatocellular Carcinoma
Clin. Cancer Res., February 1, 2007; 13(3): 944 - 952.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. T. Chang and H.-O. Adami
The enigmatic epidemiology of nasopharyngeal carcinoma.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1765 - 1777.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
M. J. Worsham, K. M. Chen, V. Meduri, A. O. H. Nygren, A. Errami, J. P. Schouten, and M. S. Benninger
Epigenetic events of disease progression in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg, June 1, 2006; 132(6): 668 - 677.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. W.Y. Chan, S. H. Wei, P. Wen, Z. Wang, D. E. Matei, J. C. Liu, S. Liyanarachchi, R. Brown, K. P. Nephew, P. S. Yan, et al.
Hypermethylation of 18S and 28S Ribosomal DNAs Predicts Progression-Free Survival in Patients with Ovarian Cancer
Clin. Cancer Res., October 15, 2005; 11(20): 7376 - 7383.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. An, I.-S. Choi, J. C. Yao, S. Worah, K. Xie, P. F. Mansfield, J. A. Ajani, A. Rashid, S. R. Hamilton, and T.-T. Wu
Prognostic Significance of CpG Island Methylator Phenotype and Microsatellite Instability in Gastric Carcinoma
Clin. Cancer Res., January 15, 2005; 11(2): 656 - 663.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. M. Das and R. Singal
DNA Methylation and Cancer
J. Clin. Oncol., November 15, 2004; 22(22): 4632 - 4642.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Sriuranpong, A. Mutirangura, J. W. Gillespie, V. Patel, P. Amornphimoltham, A. A. Molinolo, V. Kerekhanjanarong, S. Supanakorn, P. Supiyaphun, S. Rangdaeng, et al.
Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays
Clin. Cancer Res., August 1, 2004; 10(15): 4944 - 4958.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Dulaimi, I. I. de Caceres, R. G. Uzzo, T. Al-Saleem, R. E. Greenberg, T. J. Polascik, J. S. Babb, W. E. Grizzle, and P. Cairns
Promoter Hypermethylation Profile of Kidney Cancer
Clin. Cancer Res., June 15, 2004; 10(12): 3972 - 3979.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Zuo, L. Ai, P. Ratliff, J. Y. Suen, E. Hanna, T. P. Brent, and C.-Y. Fan
O6-Methylguanine-DNA Methyltransferase Gene: Epigenetic Silencing and Prognostic Value in Head and Neck Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 967 - 975.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Agathanggelou, I. Bieche, J. Ahmed-Choudhury, B. Nicke, R. Dammann, S. Baksh, B. Gao, J. D. Minna, J. Downward, E. R. Maher, et al.
Identification of Novel Gene Expression Targets for the Ras Association Domain Family 1 (RASSF1A) Tumor Suppressor Gene in Non-Small Cell Lung Cancer and Neuroblastoma
Cancer Res., September 1, 2003; 63(17): 5344 - 5351.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Dong, D.-I. Sun, N. E. Benoit, I. Kuzmin, M. I. Lerman, and D. Sidransky
Epigenetic Inactivation of RASSF1A in Head and Neck Cancer
Clin. Cancer Res., September 1, 2003; 9(10): 3635 - 3640.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Toyooka, K. O. Toyooka, K. Miyajima, J. L. Reddy, M. Toyota, U. G. Sathyanarayana, A. Padar, M. S. Tockman, S. Lam, N. Shivapurkar, et al.
Epigenetic Down-Regulation of Death-associated Protein Kinase in Lung Cancers
Clin. Cancer Res., August 1, 2003; 9(8): 3034 - 3041.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. S. Wong, D. L.-W. Kwong, J. S.-T. Sham, S. W. Tsao, W. I. Wei, Y. L. Kwong, and A. P.-W. Yuen
Promoter Hypermethylation of High-in-normal 1 Gene in Primary Nasopharyngeal Carcinoma
Clin. Cancer Res., August 1, 2003; 9(8): 3042 - 3046.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. P. Whitcomb, D. G. Mutch, T. J. Herzog, J. S. Rader, R. K. Gibb, and P. J. Goodfellow
Frequent HOXA11 and THBS2 Promoter Methylation, and a Methylator Phenotype in Endometrial Adenocarcinoma
Clin. Cancer Res., June 1, 2003; 9(6): 2277 - 2287.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Kuzmin, L. Liu, R. Dammann, L. Geil, E. J. Stanbridge, S. P. Wilczynski, M. I. Lerman, and G. P. Pfeifer
Inactivation of RAS Association Domain Family 1A Gene in Cervical Carcinomas and the Role of Human Papillomavirus Infection
Cancer Res., April 15, 2003; 63(8): 1888 - 1893.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. W. Chang, A. Chan, D. L. W. Kwong, W. I. Wei, J. S. T. Sham, and A. P. W. Yuen
Detection of Hypermethylated RIZ1 Gene in Primary Tumor, Mouth, and Throat Rinsing Fluid, Nasopharyngeal Swab, and Peripheral Blood of Nasopharyngeal Carcinoma Patient
Clin. Cancer Res., March 1, 2003; 9(3): 1033 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. H. M. Tong, R. K. Y. Tsang, K.-W. Lo, J. K. S. Woo, J. Kwong, M. W. Y. Chan, A. R. Chang, C. A. van Hasselt, D. P. Huang, and K.-F. To
Quantitative Epstein-Barr Virus DNA Analysis and Detection of Gene Promoter Hypermethylation in Nasopharyngeal (NP) Brushing Samples from Patients with NP Carcinoma
Clin. Cancer Res., August 1, 2002; 8(8): 2612 - 2619.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Widschwendter and P. A. Jones
The Potential Prognostic, Predictive, and Therapeutic Values of DNA Methylation in Cancer : Commentary re: J. Kwong et al., Promoter Hypermethylation of Multiple Genes in Nasopharyngeal Carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of Aberrant p16 Methylation in the Serum of Colorectal Cancer Patients. Clin. Cancer Res., 8: 188-191, 2002.
Clin. Cancer Res., January 1, 2002; 8(1): 17 - 21.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.